GILMAN STEVEN C - Insider Non-Derivative Transactions at Akebia Therapeutics, Inc. (AKBA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 10, 2025, GILMAN STEVEN C's relationship to Akebia Therapeutics, Inc. (AKBA) is Director, and currently has 152,830 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AKBA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

GILMAN STEVEN C - Insider Non-Derivative Transactions of AKBA Common Stock

GILMAN STEVEN C - Insider Non-Derivative Transactions at AKBA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Shares Owned After Transactions
Jun 11, 2025	Acquisition -- (Common Stock)	35700	152830
Jun 7, 2024	Acquisition -- (Common Stock)	30000	117130
Jun 7, 2023	Acquisition -- (Common Stock)	30000	87130